Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers L > Headlines for L2 Medical Development Co. > News item |
L2 Medical announces it will price a public offering of common stock
Bookrunner Roth Capital Partners assists; deal funds working capital
By Devika Patel
Knoxville, Tenn., Sept. 30 - L2 Medical Development Co. plans to price a public offering of common stock along with a secondary sale of shares and warrants, according to a Form S-1 filed Monday with the Securities and Exchange Commission. The deal has a 30-day greenshoe.
Roth Capital Partners is the bookrunning manager.
Proceeds will be used for working capital and general corporate purposes.
Based in Albuquerque, N.M., the company makes a plug and play replacement product for automotive spark plugs.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.